Cancer Lawsuit Information: Myeloma Cancer Statistics

Below are statistics relating to Myeloma cancer from the National Cancer Institute (NCI). The data indicates trends, rates, and patterns of Myeloma cancer in the United States, by sex, and race/ethnicity, survival and stage rates. The National Cancer Institute (NCI) estimates that the incidence of cancer could be reduced by as much as 80-90 percent if environmental causes such as diet, tobacco, and alcohol, as well as radiation, infectious agents, and substances in the air, water, and soil were addressed.

If you are suffering from a cancer caused by an industrial pollutant, or you were misdiagnosed by a doctor or oncologist, you may be able to file a lawsuit and get compensation for your pain and suffering, make sure your family is provided for, and help make sure that no one else in your community is exposed to dangerous carcinogens. To get your free case evaluation, fill out this simple form. Your case will be evaluated within 24 hours. If you want to help a friend who needs a cancer attorney, please click here.

The American Cancer Society estimates that 15,980 men and women (8,600 men and 7,380 women) will be diagnosed with and 11,300 men and women will die of myeloma in 2005.

The following information is based on NCI and other statistics from NCI’s analysis of SEER incidence data and NCHS mortality data.

Incidence & Mortality

From 1998-2002, the median age at diagnosis for myeloma was 70 years of age. Approximately 0.0% were diagnosed under age 20; 0.6% between 20 and 34; 3.4% between 35 and 44; 11.2% between 45 and 54; 19.0% between 55 and 64; 28.5% between 65 and 74; 27.8% between 75 and 84; and 9.4% 85+ years of age.

The age-adjusted incidence rate was 5.5 per 100,000 men and women per year. These rates are based on cases diagnosed in 1998-2002 from 13 SEER geographic areas. Incidence rates by race and sex were:

US Mortality

From 1998-2002, the median age at death for myeloma was 74 years of age. Approximately 0.0% died under age 20; 0.1% between 20 and 34; 1.4% between 35 and 44; 6.3% between 45 and 54; 14.8% between 55 and 64; 28.9% between 65 and 74; 34.5% between 75 and 84; and 13.9% 85+ years of age.

The age-adjusted death rate was 3.8 per 100,000 men and women per year. These rates are based on patients who died in 1998-2002 in the US. Death rates by race and sex were:

Trends in Rates

Trends in rates can be described in many ways. Information for trends over a fixed period of time, for example 1992-2002, can be evaluated by the annual percentage change (APC). If there is a negative sign before the number, the trend is a decrease; otherwise it is an increase. If there is an asterisk after the APC then the trend was significant, that is, one believes that it is beyond chance, i.e. 95% sure, that the increase or decrease is real over the period 1992-2002. If the trend is not significant, the trend is usually reported as stable or level. Joinpoint analyses can be used over a long period of time to evaluate when changes in the trend have occurred along with the APC which shows how much the trend has changed between each of the joinpoints.

The joinpoint trend in SEER cancer incidence with associated APC(%) for myeloma between 1975-2002 was:

The joinpoint trend in US cancer mortality with associated APC(%) for myeloma between 1975-2002 was:

Survival

Survival rates can be calculated by different methods for different purposes. The survival rates presented here are based on the relative survival rate, which measures the survival of the cancer patients in comparison to the general population to estimate the effect of cancer. The overall 5-year relative survival rate for 1995-2001 from 9 SEER geographic areas was 32.4%. Five-year relative survival rates by race and sex were: 35.8% for white men; 28.1% for white women; 36.3% for black men; 30.5% for black women.

Lifetime Risk

Based on rates from 2000-2002, 0.62% of men and women born today will be diagnosed with myeloma at some time during their lifetime. This number can also be expressed as 1 in 162 men and women will be diagnosed with myeloma during their lifetime. These statistics are called the lifetime risk of developing cancer. Sometimes it is more useful to look at the probability of developing myeloma between two age groups. For example, 0.28% of men will develop myeloma between their 50th and 70th birthdays compared to 0.19% for women.

Prevalence

On January 1, 2002, in the United States there were approximately 50,484 men and women alive who had a history of myeloma -- 27,357 men and 23,127 women. This includes any person alive on January 1, 2002 who had been diagnosed with myeloma at any point prior to January 1, 2002 and includes persons with active disease and those who are cured of their disease. Prevalence can also be expressed as a percentage and it can also be calculated for a specific amount of time prior to January 1, 2002 such as disgnosed within 5 years of January 1, 2002.

Source: National Cancer Institute www.cancer.gov

Click To Talk To Us Online

see also:

Detailed Information Myeloma Cancer Lawsuit Toxic Tort Lawyers/Attorneys
Myeloma Toxic Tort Lawsuit Lawyer/Attorney

Statistics Myeloma Cancer Statistics from Environmental Cancer Lawyers/Attorneys
Myeloma Cancer Stats: Rates, Signs, Trends, Mortality, Treatments

Myeloma Myeloma Cancer Lawsuit Toxic Tort Lawyers/Attorneys
Myeloma Toxic Tort Lawsuit Lawyer/Attorney